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ABSTRACT 
Thought and language disorders are a main feature of schizophrenia. The aim of the study is to explore 
the impact of thought disorder on therapeutic alliance and personal recovery because of its interference 
with verbal communication. Thought disorder, positive and negative symptoms (Positive and Negative 
Syndrome Scale), functioning (Modified Global Assessment of Functioning scale), insight (Scale to 
Assess Unawareness of Mental Disorder), attachment insecurity (Psychosis Attachment Measure), 
therapeutic alliance (Scale to Assess the Therapeutic Relationship ), and personal recovery (Recovery 
Assessment Scale (RAS), Integration Sealing-Over Scale) were assessed in 133 outpatients with 
schizophrenia or schizoaffective disorder at baseline and twelve months later. The data were analyzed 
by hierarchical multiple linear regression. Higher levels of thought disorder were significantly 
associated with lower clinicians’ ratings, but not with patients’ ratings of therapeutic alliance. In 
addition, lower clinicians’ ratings of therapeutic alliance were significantly linked to a more sealing 
over and less integrative recovery style. In fact, the lower therapeutic alliance ratings mediated the 
association between thought disorder and a sealing over recovery style. The results highlight the 
importance of considering thought disorder in treatment of schizophrenia and schizoaffective disorder 
which may interfere with therapeutic alliance and treatment efforts towards recovery. 
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1. Introduction 
Formal thought disorder is a multifaceted construct that encompasses a diverse set of thinking 
disturbances and manifests as a speech disorder. It reflects disorganized thoughts in terms of processes 
as opposed to content (Beck et al., 2011a) and can be distinguished in objective (e.g. derailment) and 
subjective positive forms (e.g. pressure / rush of thought) as well as in objective (e.g. poverty of 
speech) and subjective negative forms (e.g. inhibited thinking; Kircher and colleagues, 2014). Thought 
disorder has been considered to be a core feature of schizophrenia (Bleuler, 1950) and described either 
as part of the positive syndrome or as part of the disorganization syndrome, based on factor analyses 
of the symptoms of schizophrenia (Beck et al., 2011a). It occurs in about 50% of patients with 
schizophrenia and 60% of patients with schizoaffective disorder, but is not pathognomonic of 
schizophrenia spectrum disorders and can be also observed in patients with mania or depression 
(Roche et al., 2015). Thought disorder predicted psychosis transition of young people at-risk mental 
state (Katsura et al., 2014) and was also found among relatives of patients with schizophrenia 
(Manschreck et al., 2012). It is moderately stable (trait marker; Wilcox et al., 2012) but becomes 
exacerbated during the acute episode, tends to increase in severity with illness duration (Maeda et al., 
2007), and may also persist during antipsychotic treatment (Remberk et al., 2012). Thought disorder 
can be as disabling as the other symptoms of schizophrenia, limiting social and occupational 
functioning (Tirupati et al., 2004) as well as wellbeing and life satisfaction (Sigaudo et al., 2014; Tan 
et al., 2014). Furthermore, it may impede the access to many effective psychological treatments of 
schizophrenia (e.g. cognitive behavioral or narrative therapies), because it heavily interferes with the 
verbal communication in the process of therapy. Consequently, thought disorder is probably among 
the least explored and treated symptoms of schizophrenia in psychotherapy (Beck et al., 2011a). 
Efforts have thus been taken to elucidate the neurobiological basis of thought disorder (Horn et al., 
2009, 2010, 2012) which might allow for the use of recently developed treatment approaches such as 
noninvasive brain stimulation that has proven useful in other domains of schizophrenia (Homan et al., 
2011, 2012). 
 Therapeutic alliance has a crucial impact on therapy outcome, beyond therapeutic methods 
(Orlinsky et al., 2004), and this is also true for the treatment of schizophrenia (Farrelly et al., 2014; 
Priebe et al., 2011). Recently, Goldsmith and colleagues (2015) demonstrated that therapeutic alliance 
has a causal effect on symptomatic outcome of a psychological treatment for people with a first or 
second episode of a non-affective psychosis, and that poor therapeutic alliance is actively detrimental. 
So far, positive and negative symptoms, lack of insight, attitude towards treatment or medication, 
social functioning, or attachment insecurity have been studied as impediments for developing an 
effective therapeutic bond with psychotic patients (Barrowclough et al., 2010; Gumley et al., 2014; 
Jung et al., 2014; Wittorf et al., 2009). In contrast, knowledge about the impact of thought disorder on 
therapeutic alliance is sparse. Because verbal communication is one of the main means for therapists 
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to build relationship with patients (Cruz and Pincus, 2002), thought disorder may reflect a crucial 
obstacle in therapy. 
 Recovery from schizophrenia has been defined in various ways (Cavelti et al., 2012b). 
Traditionally, recovery was understood as sustained symptom remission, accompanied by functional 
rehabilitation (e.g. cognitive, social, and vocational) and reduced use of medical health services. For 
this scientific definition of recovery, the term “clinical recovery” was introduced (Bellack, 2006). 
During the last years, another definition of recovery emerged from individuals who had personally 
experienced severe mental illness (SMI) and had used mental health services (e.g. Ben-David et al., 
2014; Frese et al., 2009; Helman 2014). From consumers’ perspective, recovery refers to a personal 
process of overcoming the negative personal and social consequences of having a severe mental 
disorder and regaining a self-determined and meaningful life, beyond symptom remission and 
functional rehabilitation (Bellack, 2006). Thus, recovery is no longer seen as an event occurring solely 
within the individual, but as a dynamic interplay between the individual and its environment (Cavelti 
et al., 2012b). In this article, we will refer to the latter definition of recovery as “personal recovery” 
(Slade et al., 2012). Personal recovery which involves reconstructing illness episodes in life-narratives, 
finding meaning in psychotic experiences, and overcoming (self-) stigma may rely strongly on 
metacognitive and communicative abilities (Hasson-Ohayon et al., 2014; Salvatore et al., 2012). Even 
if it is easily conceivable that thought disorder impedes personal recovery, empirical data thereto is 
lacking. 
 As part of a larger investigation of predictors of service engagement with community mental 
health services among people with schizophrenia or schizoaffective disorder (Beck et al., 2011b; 
Cavelti et al., 2012a; Cavelti et al., 2014; Kvrgic et al., 2013), the current study aimed to explore a) the 
impact of thought disorder on therapeutic alliance, b) the impact of thought disorder and therapeutic 
alliance on personal recovery, and c) whether therapeutic alliance mediates the association between 
thought disorder and personal recovery. Thereby, we controlled for the influence of established 
predictors of therapeutic alliance and personal recovery, such as positive and negative symptoms, 
functioning, insight, and attachment style.           
2. Methods 
2.1. Participants and procedure 
Between February 2009 and March 2010 consumers of community mental health services in the 
region of Basel, Switzerland, between 18 and 65 years of age and diagnosed with schizophrenia or 
schizoaffective disorder were asked for study participation. Diagnoses were confirmed by the 
Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - IV Axis I 
Disorders (First et al., 1996). Exclusion criteria were a primary diagnosis of alcohol or substance 
dependency, an organic syndrome or learning disability, inadequate command of German, and 
homelessness. After a full explanation of the study aims and procedures, participants provided written 
informed consent. The assessment consisted of an interview (PANSS, MGAF, SUMD) conducted by 
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three well trained research psychologists as well as of questionnaires for participants (PAM, STAR-P, 
RAS) and their therapists (STAR-C, ISOS), administered at baseline (tb) and at 12-month follow-up 
(tf). Participants received a financial compensation of 40 Swiss Francs for the baseline and of 60 Swiss 
Francs for the follow-up assessment. The study was approved by the local ethics committee.  
2.2. Measures 
Severity of symptoms common in schizophrenia was assessed by the Positive and Negative Syndrome 
Scale (PANSS; Kay et al., 1987).  This semi-structured interview consists of 30 items which are rated 
on a 7-point Likert scale (“1=absent”, “7=extreme”). Several factor analytical studies have suggested 
that a five-factor model better captures PANSS structure than the original three factors proposed by 
Kay et al. (1987). Based on five-factor models reported in the literature, Wallwork et al. (2012) 
constructed a “consensus” model that might enhance comparability between studies. For our statistical 
analyses, we used the Positive, Negative, and Disorganized/Concrete subscales (Excited and 
Depressed excluded). Disorganized/Concrete encompasses the items P2 (conceptual disorganization), 
N5 (difficulty in abstract thinking), and G11 (poor attention), and was applied as an indicator of 
thought disorder in this study. Especially P2 and N5 are in line with the concept of FTD and have been 
found to positively correlate with the Thought, Language, and Communication (TLC) scale (Horn et 
al., 2010; 2012). 
The Modified Global Assessment of Functioning scale (M-GAF; Hall, 1995) was used as an 
overall measure of psychological, social, and occupation functioning, covering the range from positive 
mental health to severe psychopathology. A single score is rated ranging from 1-90, with higher scores 
indicating a higher level of global functioning. The MGAF is intended to be a generic rather than a 
diagnosis-specific scoring system. However, it has been proved a valid measure of how patients with 
schizophrenia are doing (Schwartz, 2007). 
The three global items of the semi-structured interview Scale to assess Unawareness of 
Mental Disorder (SUMD; Amador et al., 1993) were used to evaluate patient’s awareness of having a 
mental disorder, of achieved effects of medication, and of social consequences of having a mental 
disorder. These dimensions of insight were rated on a 5-point Likert scale (1=“aware” to 
5=“unaware”), with higher scores indicating poorer awareness. 
The attachment style was measured by the Psychosis Attachment Measure (PAM; Berry et al., 
2006). This self-rating scale was developed to assess insecure attachment in adults with psychosis. It 
includes 16 items that are rated on a 5-point Likert scale from 0=”strongly disagree” to 4=”strongly 
agree”. A high overall total score reflects a pronounced insecure attachment style.  
The Scale to Assess the Therapeutic Relationship-Patient Version (STAR-P) and Clinician 
Version (STAR-C; McGuire-Snieckus et al., 2007) was applied to measure therapeutic alliance in 
community psychiatry. Each version consists of 12 items, rated on a 5-point Likert scale, with 
0=”never” to 4=”always”. Higher total scores indicate better therapeutic alliance. 
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Several aspects of personal recovery were assessed: The Recovery Assessment Scale (RAS; 
Corrigan et al., 2004) measures subjective experience of the recovery process, including the extent to 
which people are living a satisfying, fulfilling, and hopeful life and developing meaning and purpose 
regardless of the presence of mental symptoms. The RAS is plausibly the most commonly used 
recovery measure in research and have been favoured by narrative reviews about recovery measures 
(Salzer and Brusilovskiy, 2014). It is a self-report measure which consists of 41 items that are rated on 
a 5-point Likert scale, ranging from 1 (“strongly disagree”) to 5 (“strongly agree”). A factor analysis 
resulted in five factors, totalling 24 items: Personal Confidence and Hope, Willingness to ask for Help, 
Goal and Success Orientation, Reliance on Others, and Not Dominated by Symptoms. In addition, the 
Integration Sealing-Over Scale (ISOS; McGlashan, 1987) was used by clinicians to evaluate their 
patient’s prevailing recovery style. The recovery style reflects the various coping strategies people use 
when dealing with psychosis and reflects psychological adjustment to the mental disorder. Patients 
with an integrative recovery style are described a “patients who are more likely to see their psychotic 
experience as something that is a part of them and has arisen from their life context, as something that 
they are responsible for, and as something that may be used as a source of information about 
themselves and their conflicts, relationships, and behaviour” (Staring et al., 2014, p. 295). Conversely, 
patients with a sealing over recovery style “tend to distance themselves from their psychotic 
experiences, viewing them as causally independent, globally negative interruptions to their lives” 
(Staring et al., 2014, p. 295). The ISOS comprises of 13 opposite statements related to both recovery 
styles. In deviation from the original recommendation to derive a global rating score, each of the 
individual items was evaluated separately on a 6-point scale (1=”integration” to 6=”sealing over”, as 
proposed by Modestin et al. (2004). The higher the total score, the more pronounced is the tendency 
towards sealing over. 
2.3. Statistical analyses 
All statistical analyses were conducted based on 133 complete data sets, using IBM SPSS Statistics 
22. For a flowchart of the study and a comparison between participants who completed the study and 
those who dropped out, please see Cavelti et al. (2014).  
Hierarchical multiple linear regression analyses were used to test the associations between 
thought disorder, therapeutic alliance and personal recovery. Blocks of predictors were entered 
stepwise. The contribution of each block to the explained outcome variance was examined by testing 
the difference in F-scores on significance (∆F, P). If the block did not significantly contribute to the 
amount of explained outcome variance, the coefficients were not further interpreted (Frazier et al., 
2004).  
To test the impact of thought disorder on therapeutic alliance, two separate analyses were 
conducted with STAR-C and STAR-P at follow-up, respectively, as criterion variable. The first block 
of predictors included STAR-C or -P at baseline to control for baseline differences in therapeutic 
alliance. The second block comprised the baseline scores of established predictors of therapeutic 
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alliance, i.e. attachment style (PAM), insight (SUMD), functioning (MGAF), as well as positive and 
negative symptoms (PANSS Positive, PANSS Negative). The third block considered the predictor of 
special interest, i.e. the thought disorder score at baseline (PANSS Disorganized/Concrete).  
To test the impact of thought disorder and therapeutic alliance on personal recovery, separate 
analyses were conducted with the ISOS total score and the RAS subscales at follow-up as criterion 
variables. The first block of predictors included the ISOS or the RAS subscale, respectively, at 
baseline to control for baseline differences in recovery style or subjective experiences of recovery. The 
second block comprised the baseline score of global functioning (MGAF) and symptoms (PANSS 
Positive, PANSS Negative, PANSS Disorganized/Concrete). The third block considered therapeutic 
alliance at baseline, while STAR-C was used as predictor for the ISOS total score and STAR-P as 
predictor for the RAS subscales.  
To test whether therapeutic alliance mediates the impact of thought disorder on personal 
recovery within the two-wave longitudinal design of the study, two paths had to be estimated: First, 
the path (f) from the predictor variable (thought disorder) at baseline to the mediator variable 
(therapeutic alliance) at follow-up while controlling for the mediator variable (therapeutic alliance) at 
baseline and, second, the path (g) from the mediator variable (therapeutic alliance) at baseline to the 
outcome variable (personal recovery) at follow-up while controlling for the outcome variable 
(personal recovery) at baseline. The product of the two paths (f*g) represents an estimation of the 
mediation (or indirect) effect of thought disorder at baseline on personal recovery at follow-up (Cole 
and Maxwell, 2003). The significance of the indirect effect was tested by dividing the product of the 
two paths by the standard error term proposed by Kenny et al. (1998), √g2sf2 + f2sg2 + sf2sg2, where f 
and g are unstandardized regression coefficients and sf and sg are their standard errors. The mediated 
effect divided by its standard error yields a z-score of the mediated effect. If the z-score is greater than 
1.96, the mediation effect is significant at the 0.05 level. The 95% confidence intervals around the 
estimate of the indirect effect were calculated by the product of the paths f and g ±sfgz.975, where 
z.975 is equal to the constant 1.96 and sfg is the standard error term calculated earlier. Mediation is 
confirmed if the confidence interval does not include zero (Frazier et al., 2004). 
3. Results 
3.1. Descriptive statistics 
Of the 133 completers, 47 (35.4%) were female. The mean age at study begin was 44.48 years (SD = 
11.88). The majority lived alone (n = 73; 54.9%) and had neither a stable partnership (of at least three 
months duration, n = 102; 76.7%) nor children (n = 98; 73.7%). On average, they received 12.34 years 
of education (SD = 2.98). Most participants were unemployed (neither on the free nor on the protected 
market) (n = 71; 53.4%) and received a governmental disability annuity (n = 100; 75.2%). Eighty-nine 
participants (66.9%) were diagnosed with schizophrenia and 44 (33.1%) with schizoaffective disorder. 
On average, participants had been mentally ill since 18.06 years (SD = 12.05) and treated in the 
community mental health services since 6.89 years (SD = 6.21). The majority (n = 128; 96.2%) 
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received an antipsychotic medication, usually at least one second-generation agent (n = 122; 91.7%). 
In addition to the antipsychotic medication, twenty-two participants (16.5%) received a mood 
stabilizer and 44 participants (33.1%) an antidepressant.  
 Table 1 contains reliability scores, means and standard deviations of the variables at baseline 
and follow-up.   
 
Please, insert Table 1 here. 
 
3.2. The impact of thought disorder on therapeutic alliance 
The results regarding the impact of thought disorder on therapeutic alliance are presented separately 
for clinicians’ and patients’ STAR ratings.  
Higher levels of thought disorder at baseline were significantly associated with lower 
clinicians’ ratings of therapeutic alliance twelve months later. In contrast, positive and negative 
symptoms, functioning, insight and attachment style at baseline did not have a significant impact on 
clinicians’ estimates of therapeutic alliance at follow-up (see Table 2, part 1).   
We found no significant influence of neither thought disorder, nor positive and negative 
symptoms, functioning, insight, or attachment style at baseline on patients’ ratings of therapeutic 
alliance at follow up (see Table 2, part 2). 
 
Please, insert Table 2 here. 
 
3.3.  The impact of thought disorder and therapeutic alliance on personal recovery  
The results regarding the impact of thought disorder and therapeutic alliance on personal recovery are 
presented separately for clinicians’ (ISOS) and patients’ (RAS) ratings of personal recovery. 
Higher levels of thought disorder, negative symptoms, and functioning, and lower clinicians’ 
ratings of therapeutic alliance at baseline were significantly associated with a more sealing-over and 
less integrative recovery style twelve months later. In contrast, there was no significant impact of 
positive symptoms at baseline on the recovery style at follow-up (see Table 3, part 1).  
 With regard to patients’ ratings of personal recovery, a better therapeutic alliance at baseline 
was significantly linked to a higher willingness to ask for help at follow-up, while neither symptoms 
(positive, negative, thought disorder) nor global functioning had an impact on willingness to ask for 
help (see Table 3, part 2). However, we found no significant associations between thought disorder or 
therapeutic alliance with feeling of not being dominated by symptoms (thought disorder: B(SE) = 
0.02(0.08), β = 0.02, p = 0.793; therapeutic alliance: B(SE) = 0.05(0.03), β = 0.16, p = 0.052; R2 = 
0.29, F(6,126) = 8.50, p = 0.001), personal confidence and hope (thought disorder: B(SE) = -
0.14(0.17), β = 0.07, p = 0.413; therapeutic alliance: B(SE) = 0.07(0.06), β = 0.09, p = 0.287; R2 = 
0.39, F(6,126) = 13.29, p = 0.001), goal and success orientation (thought disorder: B(SE) = -
  8/15 
0.01(0.10), β = -0.01, p = 0.946; therapeutic alliance: B(SE) = -0.01(0.04), β = -0.03, p = 0.686; R2 = 
0.36, F(6,126) = 11.92, p = 0.001), or reliance on others (thought disorder: B(SE) = 0.01(0.09), β = 
0.01, p = 0.968; therapeutic alliance: B(SE) = 0.05(0.03), β = 0.12, p = 0.148; R2 = 0.32, F(6,126) = 
9.67, p = 0.001). 
  
Please, insert Table 3 here. 
 
3.4. Therapeutic alliance as mediator between thought disorder and personal recovery  
The question whether therapeutic alliance mediates the association between thought disorder and 
personal recovery was tested based on clinicians’ ratings of therapeutic alliance and of patients’ 
recovery style, because thought disorder failed to significantly impact patients’ ratings of therapeutic 
alliance (see 3.1.) which is a precondition for mediation.   
Higher levels of thought disorder at baseline were significantly associated with lower 
clinicians’ ratings of therapeutic alliance at follow-up (B(SE) = -0.45(0.15), β = -0.23., p = 0.004, R2 = 
0.22, F(2,130) = 17.80, p = 0.001). Additionally, lower clinicians’ ratings of therapeutic alliance at 
baseline predicted a more sealing over and less integrative recovery style at follow-up (B(SE) = -
0.05(0.02), β = -0.25., p = 0.002, R2 = 0.25, F(2,130) = 21.57, p = 0.001). Finally, the indirect effect 
from thought disorder to recovery style was also significant (z-score = 2.08 > 1.96, 95% CI[0.04, 
0.001]), confirming therapeutic alliance as a mediator between thought disorder and a recovery style 
of sealing over.  
4. Discussion 
4.1. Discussion of the results 
The purpose of the current study was to examine the associations between thought disorder, 
therapeutic alliance and personal recovery using a regression analytical approach. We found that 
higher levels of thought disorder at baseline predicted lower clinicians’ ratings of therapeutic alliance 
at follow-up, independently of positive and negative symptoms, functioning, insight, and attachment 
style. Empirical data on the impact of formal thought disorder on therapeutic alliance in treatment of 
psychosis is rare, making it difficult to compare our results with previous studies. In a qualitative study 
on the factors differentiating patients who progress or failed to progress in cognitive-behavioural 
therapy for psychosis, McGowan and colleagues (2005) reported that therapists were concerned with 
the importance of patients’ “clear and logical thinking” in making progress in therapy and questioned 
their ability to help patients with illogical thinking. The authors did not report symptoms, such as 
thought disorder, of their study participants. However, illogicality has been described as a hallmark of 
formal thought disorder (Andreasen, 1979). Thus, our results may indicate that thought disorder, such 
as illogicality, may contribute to a feeling of confusion in clinicians; they may question the ability to 
bond with the patient as well as to jointly define and reach therapeutic goals, resulting in lower ratings 
of the therapeutic alliance. By contrast, we found no associations between thought disorder at baseline 
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and patients’ ratings of therapeutic alliance at follow-up. This result may be explained by the fact that 
patients’ awareness of thought disorder is generally weak (Barrera et al., 2009). In addition, other 
factors than thought disorder, such as patients’ perceived therapist genuineness and competence (Jung 
et al., 2015) or attitude to treatment (Barrowclough et al., 2010), may be more important predictors of 
patients’ estimates of therapeutic alliance.  
We found higher levels of thought disorder at baseline to be linked to a more sealing over and 
less integrative recovery style at follow-up. This is in line with a recent study that reported higher 
symptom levels of cognitive disorganization on the PANSS for the sealed-over group (Bell et al., 
2005). Maybe that thought disorder interferes with the patients’ ability to “understand the psychotic 
experience and to establish continuity of his or her mental activity and personality from before the 
psychotic experience, during psychosis, and through recovery” (Modestin et al. 2004, p. 1). In our 
study, higher levels of negative symptoms and higher levels of functioning at baseline predicted also a 
sealing over recovery style at follow-up. In contrast, in the study by Modestin and colleagues (2009) a 
tendency towards sealing over correlated positively with the PANSS negative symptom scale, but 
negatively with the MGAF. The association between a sealing over recovery style and higher MGAF 
scores found in our study may indicate that when functioning improves, individuals become more 
aware of the extent to which psychosis impaired role functioning in the past, motivating sealing-over. 
This interpretation is supported by evidence suggesting that patients who seal over are those who see 
greater loss and shame in their psychosis, motivating denial (Staring et al., 2014; Tait et al., 2003). In 
our study no significant association was found between thought disorder and patients’ subjective 
experiences of recovery as measured by the RAS subscales. However, this result is consistent with the 
broad consumer literature espousing that personal recovery is possible even in the presence of 
disabling symptoms (Cavelti et al., 2012b; Salzer and Brusilovskiy, 2014).  
Lower clinicians’ ratings of therapeutic alliance at baseline were linked to a more sealing over 
and less integrative recovery style at follow-up. Furthermore, therapeutic alliance was found to 
mediate the adverse association between thought disorder and a recovery style of sealing over. Recent 
results indicate that recovery styles can change over time (Thompson et al., 2003) and can be modified 
by psychotherapeutic interventions (Jackson et al., 1998). Considering the importance of therapeutic 
alliance for treatment outcome (e.g. Goldsmith et al., 2015), our results may denote that thought 
disorder can interfere with therapeutic alliance, which, in turn, can hamper treatment efforts to 
facilitate patients’ psychological adjustment to psychosis. Yet, this interpretation needs to be 
addressed cautiously because we examined the influence of therapeutic alliance on recovery style and 
not on outcome (i.e. symptom remission or functional improvement) per se. However, our 
interpretation is supported by evidence suggesting that an integrative recovery style in patients with 
schizophrenia spectrum disorders predicts higher rates of symptom remission (Staring et al., 2014; 
Thompson et al., 2003) and functioning (McGlashan, 1987; Modestin et al., 2009; Thompson et al., 
2003).  
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Finally, higher patients’ ratings of therapeutic alliance at baseline predicted a greater 
willingness to ask for help at follow-up, but showed no associations with the other RAS subscales at 
follow-up. Recently, Moran and colleagues (2014) reported a significant positive correlation between 
working alliance and all subscales of the RAS in a cross-sectional study on 72 people with serious 
mental illness, including schizophrenia, schizoaffective, bipolar, and/or depressive disorders. 
Moreover, a positive bidirectional relationship between working alliance and recovery (assessed by the 
RAS) was found in a longitudinal study examining 61 people with psychotic spectrum illnesses (Hicks 
et al., 2012), indicating that improvement in therapeutic alliance positively influences gains in 
recovery and that gains in recovery also facilitate stronger therapeutic alliance. Thus, our finding adds 
to the growing evidence about the significance of the therapeutic alliance in treatment of psychosis 
(Farrelly et al., 2014; Goldsmith et al., 2015; Priebe et al., 2011) and is align with the broader field of 
psychotherapy research which emphasizes the value of the therapeutic relationship across various 
types of psychological problems and mental disorders (Orlinsky et al., 2004).  
4.2. Limitations and conclusion 
The study had some shortcomings which are important to consider: First, thought disorder was 
assessed by a general psychopathology scale (Wallwork et al., 2012) and not a symptom specific 
measure, such as the Thought, Language, and Communication (TLC) scale (Andreasen, 1979) or the 
Thought and Language Disorder (TALD) scale (Kircher et al., 2014). However, the PANSS 
Disorganization/Concrete subscale has been successfully used in other empirical studies investigating 
thought and language disorder in patients with psychosis (e.g. Herzig et al., 2015). Second, the 
measure used to assess role functioning mixes aspects of psychopathology and socio-occupational 
functioning. Third, due to the oversampling of male participants in our study, the exclusion of patients 
with a comorbid diagnosis of alcohol or drug abuse from study participation, and the rather small 
sample size for the complexity of multivariate analyses, the results have to be replicated on larger, 
more representative samples. Fourth, even if comparable to other studies, the explained outcome 
variance was moderate, raising the question of other crucial predictors of therapeutic alliance and 
personal recovery. For example, metacognition has been described as a significant predictor of 
personal recovery (Lysaker and Dimaggio, 2014). In this regard, it is interesting to note that cognitive 
disorganization symptoms demonstrated inverse associations with metacognitive abilities (Hamm et 
al., 2012). Another neglected predictor of therapeutic alliance in this study may be depression. 
However, evidence regarding the link between depression and therapeutic alliance in treatment of 
psychosis is inconsistent with some studies reporting a significant association between higher 
depression scores and lower therapeutic alliance ratings (Barrowclough et al., 2010; Mulligan et al., 
2014), while other studies failed to found a significant association (Jung et al., 2014; Kvrgic et al., 
2013). Fifth, both the therapeutic alliance and the recovery style were rated by clinicians. Thus, we 
cannot fully rule out the possibility that the significant association found between lower ratings of 
therapeutic alliance at baseline and a sealing over recovery style at follow-up is a methodological 
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artefact. Sixth, causal interpretations of our correlational study results are not appropriate and we did 
not examine opposite or bi-directional relationships between variables (e.g. personal recovery may 
also influence therapeutic alliance; e.g. Hicks et al., 2012; Kvrgic et al., 2013). Finally, while our 
study focused specifically on personal recovery as outcome, future studies may investigate the impact 
of thought disorder on aspects of clinical recovery, such as symptom remission and functional 
improvement.  
 Despite these limitations, the current explorative study provided first evidence for a negative 
impact of formal thought disorder on clinicians’ ratings of therapeutic alliance and the patients’ 
recovery style in outpatients with schizophrenia or schizoaffective disorders. We did not find evidence 
for an influence of thought disorder on patients’ ratings of therapeutic alliance and personal recovery 
as assessed by the RAS. However, this does not imply evidence for the absence of such an effect, the 
testing of which would require a different study design and most probably a larger study sample. 
Given that so far patients with thought disorder have been regularly excluded from therapy studies 
(Beck et al., 2011a) and that therapeutic alliance is one of the most important predictors of treatment 
outcome in psychosis (Farrelly et al., 2014; Goldsmith et al., 2015; Priebe et al., 2011), our results 
highlight the need for future research about how clinicians can deal with thought disordered patients in 
therapy in order to best support their recovery process. 
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Table 1. Cronbach’s alpha coefficients (α), means (M) and standard deviations (SD) of  




















Notes. ISOS = Integration Sealing-Over Scale, MGAF = Modified Global Assessment of  
Functioning, PAM = Psychosis Attachment Measure, PANSS = Positive And Negative  
Syndrome Scale, RAS = Recovery Assessment Scale, STAR-C/P = Scale to Assess  
Therapeutic Relationship Clinician Version / Patient Version, SUMD = Scale to assess  
Unawareness of Mental Disorder. Higher scores indicate higher levels of the variable, 
if not otherwise specified. 
a reversed scored; higher scores indicate lower levels of insight 
b higher scores indicate more sealing over and less integration 
c modal value 
 
Variable Range αtb Mtb (SDtb) αtf Mtf (SDtf) 
PANSS Positive 4-28 0.78 8.03 (4.01) 0.67 7.12 (3.21) 
PANSS Negative 6-42 0.82 11.21 (4.82) 0.84 11.25 (5.03) 
PANSS Disorganized/Concrete 3-18 0.67 7.30 (2.86) 0.64 7.40 (2.67) 
PAM  0-48 0.69 19.96 (6.7) 0.74 18.93 (7.22) 
SUMD, Mental Disordera 1-5 - 1.98 (1.41) - 1.95 (1.38) 
SUMD, Medicationa 1-5 - 1.74 (1.25) - 1.73 (1.18) 
SUMD, Social Consequencesa 1-5 - 2.05 (1.48) - 2.05 (1.45) 
MGAF 1-90 - 50.35 (10.46) - 50.73 (9.44) 
STAR-C 0-48 0.72 38.10 (6.40) 0.75 37.76 (5.59) 
STAR-P 0-48 0.64 37.55 (7.79) 0.66 37.45 (6.96) 
ISOSb / c 1-6 - 3.34 (1.61) - 3.22 (1.28) 
RAS Personal Confidence and Hope 9-45 0.81 32.95 (6.31) 0.80 33.61 (5.96) 
RAS Willingness to Ask for Help 3-15 0.87 12.25 (2.54) 0.73 12.27 (2.32) 
RAS Goal and Success Orientation 5-25 0.56 19.14 (3.30) 0.64 19.55 (3.46) 
RAS Reliance on Others 4-20 0.60 15.38 (2.92) 0.63 15.40 (3.05) 
RAS Not Dominated by Symptoms 3-15 0.65 10.62 (2.70) 0.67 10.77 (2.76) 
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Table 2. Predicting therapeutic alliance at one year follow-up: Results from hierarchical multiple linear regression analyses  
Outcome Predictors B (SE)  t (df) p R2 F (df) p 
STAR-C tf STAR-C tb 
PAM tb 
SUMD, Mental Disordera tb 
SUMD, Medicationa tb 
SUMD, Social Consequencesa tb 
MGAF tb 
PANSS Positive tb 
PANSS Negative tb 
PANSS Disorganized/Concrete tb 
0.31 (0.07) 



































0.24  4.23 (9,123) 0.001 
STAR-P tf STAR-P tb 
PAM tb 
SUMD, Mental Disordera tb 
SUMD, Medicationa tb 
SUMD, Social Consequencesa tb 
MGAF tb 
PANSS Positive tb 
PANSS Negative tb 





































0.31 6.13 (9,123) 0.001 
Notes. tb = baseline, tf = follow-up, MGAF = Modified Global Assessment of Functioning, PAM = Psychosis Attachment Measure,  
PANSS = Positive And Negative Syndrome Scale, STAR-C/P = Scale to Assess Therapeutic Relationship Clinician Version / Patient  
Version, SUMD = Scale to assess Unawareness of Mental Disorder. Higher scores indicate higher levels of the variable, if not otherwise  
specified. 
a reversed scored; higher scores indicate lower levels of insight 
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Table 3. Predicting personal recovery at one-year follow-up: Results from hierarchical multiple linear regression analyses 
Outcome Predictors B (SE)  t (df) p R2 F (df) p 
ISOSa tf ISOSa tb 
MGAF tb 
PANSS Positive tb 
PANSS Negative tb 


























0.32 10.06 (6,126) 0.001 
RAS 
Willingness 
to Ask for 
Help tf 
RAS Willingness to Ask for Help tb 
MGAF tb 
PANSS Positive tb 
PANSS Negative tb 


























0.36 11.90 (6,126) 0.001 
Notes. tb = baseline, tf = follow-up, ISOS=Integration Sealing-Over Scale, MGAF = Modified Global Assessment of Functioning, PAM =  
Psychosis Attachment Measure, PANSS = Positive And Negative Syndrome Scale, RAS = Recovery Assessment Scale, STAR-C/P = Scale  
to Assess Therapeutic Relationship Clinician Version / Patient Version, SUMD = Scale to assess Unawareness of Mental Disorder. Higher  
scores indicate higher levels of the variable, if not otherwise specified. 
a higher scores indicate more sealing over and less integration 
 
 
 
 
